PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28413487-4	2017	Vandetanib suppressed the expression of the mesenchymal markers ADAM10 and ADAM17 in ARPE19/EBV cells, and also upregulated epithelial cell markers of the RPE cells, E-cadherin and N-cadherin.	vandetanib	0-10	ADAM metallopeptidase domain 10	Homo sapiens	64-70	
28413487-6	2017	Furthermore, co-treatment with vandetanib and an ADAM10 inhibitor (GI254023X) or ADAM17 inhibitor (Marimastat) synergistically prevented migration and the expression of vimentin, Snail and alpha-smooth muscle actin by regulating extracellular signal-regulated kinase and p38 mitogen-activated protein kinase.	vandetanib	31-41	ADAM metallopeptidase domain 10	Homo sapiens	49-55